Insider Transactions in Q1 2024 at 2seventy Bio, Inc. (TSVT)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 26
2024
|
Casdin Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
40,000
+1.96%
|
$200,000
$5.1 P/Share
|
Mar 25
2024
|
Casdin Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
330,000
+14.41%
|
$1,650,000
$5.07 P/Share
|
Mar 22
2024
|
Casdin Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
147,377
+8.29%
|
$736,885
$5.12 P/Share
|
Mar 21
2024
|
Casdin Capital, LLC Director |
BUY
Open market or private purchase
|
Indirect |
300,000
+16.83%
|
$1,200,000
$4.9 P/Share
|
Mar 20
2024
|
Charles W. Newton |
BUY
Grant, award, or other acquisition
|
Direct |
16,600
+50.0%
|
-
|
Jan 08
2024
|
William D Baird Iii President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
91,000
+26.5%
|
-
|
Jan 08
2024
|
Nick Leschly President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
235,000
+15.11%
|
-
|
Jan 08
2024
|
Philip D Gregory Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
79,438
+20.38%
|
-
|
Jan 05
2024
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
1,380
-0.85%
|
$4,140
$3.75 P/Share
|
Jan 05
2024
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
1,554
-0.14%
|
$4,662
$3.75 P/Share
|
Jan 05
2024
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
795
-0.34%
|
$2,385
$3.75 P/Share
|
Jan 03
2024
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
33,651
-17.14%
|
$100,953
$3.87 P/Share
|
Jan 03
2024
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,613
-9.96%
|
$76,839
$3.87 P/Share
|
Jan 03
2024
|
Nick Leschly President and CEO |
SELL
Open market or private sale
|
Direct |
72,312
-6.24%
|
$216,936
$3.87 P/Share
|